Veradermics Files for Initial Public Offering to Fund Hair-Growth Pill

Veradermics Inc. filed for an initial public offering to help commercialize its hair re-growth pill.

Led by dermatologist co-founders Reid Waldman and Tim Durso, Veradermics is developing an oral, non-hormonal treatment for men and women with pattern hair loss, a condition that affects 80 million people in the US, according to a filing Friday with the US Securities and Exchange Commission.